These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 12546894)

  • 21. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
    Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
    Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment-based drug design: combining philosophy with technology.
    Bartoli S; Fincham CI; Fattori D
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):422-9. PubMed ID: 17659483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lead generation--enhancing the success of drug discovery by investing in the hit to lead process.
    Alanine A; Nettekoven M; Roberts E; Thomas AW
    Comb Chem High Throughput Screen; 2003 Feb; 6(1):51-66. PubMed ID: 12570752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based screening and design in drug discovery.
    van Dongen M; Weigelt J; Uppenberg J; Schultz J; Wikström M
    Drug Discov Today; 2002 Apr; 7(8):471-8. PubMed ID: 11965396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation phenotypic screening.
    Warchal SJ; Unciti-Broceta A; Carragher NO
    Future Med Chem; 2016 Jul; 8(11):1331-47. PubMed ID: 27357617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtual screening in drug design and development.
    Sousa SF; Cerqueira NM; Fernandes PA; Ramos MJ
    Comb Chem High Throughput Screen; 2010 Jun; 13(5):442-53. PubMed ID: 20236061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging methods for ensemble-based virtual screening.
    Amaro RE; Li WW
    Curr Top Med Chem; 2010; 10(1):3-13. PubMed ID: 19929833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug discovery: selecting the optimal approach.
    Sams-Dodd F
    Drug Discov Today; 2006 May; 11(9-10):465-72. PubMed ID: 16635811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a new drug--from target identification to ultra-high-throughput screening.
    Golz S; Hüser J
    Clin Lab; 2007; 53(1-2):77-9. PubMed ID: 17323829
    [No Abstract]   [Full Text] [Related]  

  • 36. Virtual screening: are we there yet?
    Jalaie M; Shanmugasundaram V
    Mini Rev Med Chem; 2006 Oct; 6(10):1159-67. PubMed ID: 17073716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating molecular design resources within modern drug discovery research: the Roche experience.
    Stahl M; Guba W; Kansy M
    Drug Discov Today; 2006 Apr; 11(7-8):326-33. PubMed ID: 16580974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual screening in drug discovery -- a computational perspective.
    Reddy AS; Pati SP; Kumar PP; Pradeep HN; Sastry GN
    Curr Protein Pept Sci; 2007 Aug; 8(4):329-51. PubMed ID: 17696867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging trends in high-throughput screening.
    Entzeroth M
    Curr Opin Pharmacol; 2003 Oct; 3(5):522-9. PubMed ID: 14559099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virtual compound screening in drug discovery.
    Stumpfe D; Ripphausen P; Bajorath J
    Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.